Levemir 100IU/ml Flexpen 3 ml

Levemir 100IU/ml Flexpen 3 ml is used for the management and treatment of type 1 and type 2 diabetes, especially in persons whose sugar levels are too high and cannot be only controlled by dieting and exercising. It is used to improve the sugar levels in the blood in persons dealing with diabetes mellitus in both children (above 2 years of age) and adults. Diabetes occurs when the body does not produce enough insulin to control the level of blood sugar. It is a condition in which blood glucose levels are above average. Insulin is the hormone that controls sugar levels in your blood. 

Levemir 100IU/ml Flexpen 3 ml contains Insulin Detemir as its active ingredient. It is a recombinant human insulin analogue that is equivalent to regular human insulin. It works by replacing the natural insulin produced by the body and helps move sugar from the blood to different body tissues, where it is used as energy. Levemir 100IU/ml Flexpen 3 ml has a more rapid onset of action and a long duration of action, up to 24 hours of basal insulin coverage. Treatment with Levemir 100IU/ml Flexpen 3 ml helps to prevent complications from your diabetes.

Your doctor will advise you on how to use the Levemir 100IU/ml Flexpen 3 ml. It should be administered at least 0-15 minutes before or soon after meals. The common side effects of Levemir 100IU/ml Flexpen 3 ml are hypokalaemia (low potassium levels), hypoglycemia (low blood sugar levels), local injection site reactions like lipodystrophy (fat deposition under the skin), rash, and pruritus (itch skin). Most of these side effects of Levemir 100IU/ml Flexpen 3 ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Do not skip any doses or stop taking Levemir 100IU/ml Flexpen 3 ml suddenly without consulting your doctor. Consult your doctor before taking Levemir 100IU/ml Flexpen 3 ml if you are pregnant or breastfeeding. Levemir 100IU/ml Flexpen 3 ml should not be given to children below 10 years. Avoid alcohol consumption while taking Levemir 100IU/ml Flexpen 3 ml as it might increase side effects. Levemir 100IU/ml Flexpen 3 ml may cause hypoglycaemia, so drive only if you are alert. Inform your doctor about all the medications you are taking and your health condition to rule out any unpleasant side effects.

Levemir 100IU/ml Flexpen 3 ml belongs to the category of the anti-diabetic drug indicated in the treatment of type 1 and type 2 diabetes. This medicine is primarily prescribed to people whose blood sugar levels are high and are not even controlled by diet and exercise alone. Levemir 100IU/ml Flexpen 3 ml is a fast-acting form of insulin that helps lower blood sugar levels after the intake of food. It helps in improving glycaemic control, which in turn decreases the risk of progression of complications of diabetes like damage to the retina (retinopathy), damage to the kidney (nephropathy), damage of nerve cells (neuropathy), delayed wound healing, diabetic foot ulcer, and others.

• Local injection site reactions (such as reddening, unusually intense pain on injection, itching, hives, swelling, or inflammation)
• Hypoglycemia (low blood sugar levels)
• Hypokalaemia (low potassium levels)
• Lipodystrophy (fat deposition under the skin)
• Rash
• Pruritus (itchy skin)

Do not take or stop this medicine if the doctor does not advise you to do so. Brief the doctor about your medical history and whether you have any heart, kidney, or liver diseases, low blood sugar (hypoglycaemia), and low potassium levels in the blood (hypokalaemia) before starting Levemir 100IU/ml Flexpen 3 ml. Do not share an injection pen, cartridge, or syringe with another person, even if the needle is changed. Do not inject Levemir 100IU/ml Flexpen 3 ml daily at the same injection site since it may cause skin changes, such as lumps under the skin. Do not drive or operate machinery if you experience blurred vision, dizziness or drowsiness due to extremely low or high blood sugar. It is advised to avoid your alcohol intake while using Levemir 100IU/ml Flexpen 3 ml to avoid low blood sugar levels further. Pregnant and breastfeeding women should consult their doctor before starting this medication. Levemir 100IU/ml Flexpen 3 ml can be given safely to children provided, it is prescribed by a child specialist.

Drug-Drug Interaction: Levemir 100IU/ml Flexpen 3 ml may have an interaction with drugs that may increase the risk of antiarrhythmic (disopyramide), hemorheological agents (pentoxifylline), antidiabetic medicinal products (pramlintide, glucagon), beta-blockers (metoprolol), diuretics (furosemide ), bleeding disorder drugs (octreotide), antipsychotic (propoxyphene, phenothiazines), estrogens, progestins (e.g. in oral contraceptives), protease inhibitors and atypical antipsychotic medicinal products (olanzapine and clozapine)., thyroid hormones (levothyroxine), anti-asthmatics (albuterol, epinephrine, terbutaline), antidepressant medications (fluoxetine, lithium), lipid-lowering pills (reserpine, niacin, clonidine, fenofibrate, guanethidine), pain killers (aspirin) and antibiotics (isoniazid).

Drug-Food Interaction: Levemir 100IU/ml Flexpen 3 ml may interact with ayurvedic, homoeopathy, Unani, herbal supplements, or OTC items. Tell your doctor if you are using these products. Try to avoid consuming alcoholic beverages with Levemir 100IU/ml Flexpen 3 ml, as they may increase or decrease your blood sugar level.

Drug-Disease Interaction: Levemir 100IU/ml Flexpen 3 ml should not be given to patients with kidney or liver disease, low blood sugar/glucose levels (hypoglycaemia), or low potassium levels (hypokalaemia).

• ASPIRIN
• BUDESONIDE+FORMOTEROL
• METOPROLOL
• FUROSEMIDE

• Exercise may lower your body’s need for insulin during and for some time after the physical activity.
• Exercise may also speed up the effect of an insulin dose, especially if the exercise involves the area of the injection site (for example, the leg should not be used for injection just before running).
• Discuss with your doctor how you should adjust your insulin regimen to accommodate exercise. 
• Avoid eating sugar food and prefer food cooked food low in calories.
• When travelling across more than 2 time zones, you should talk to your doctor concerning adjustments in your insulin schedule.

• Your doctor may tell you to monitor your potassium levels, as prolonged administration causes hypokalemia (low potassium levels). 
• Your doctor may advise regular monitoring of blood sugars.

Type 1 diabetes: This is a condition in which the immune system destroys insulin-making cells in the pancreas, called beta cells. The pancreas produces little or no insulin. The condition is usually diagnosed in children and young people, so it used to be called juvenile diabetes.

Type 2 diabetes: It is a chronic or life-long condition in which cells of the body fail to respond to insulin, and in later stages, the body even fails to produce enough amount of insulin. It comprises around 90% of total diabetes cases. This condition makes the body rely on different energy sources in muscles, tissues, and organs. This disease develops gradually, and the early symptoms include constant hunger, lack of energy, fatigue, weight loss, excessive thirst, frequent urination, dry mouth, itchy skin, and blurry vision. Persons who are middle-aged or older are most likely to have type 2 diabetes, so it is also called adult-onset diabetes.

The risks of uncontrolled diabetes include damaged retina of the eyes or blindness, loss of limbs, nerve problems, kidney problems, sexual dysfunction, and increased possibility of heart attack or stroke.